SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001299933-06-003242
Filing Date
2006-05-08
Accepted
2006-05-08 16:22:06
Documents
3
Period of Report
2006-05-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.01: Changes in Control of Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_12259.htm 8-K 19492
2 EX-99.1 exhibit1.htm EX-99.1 36229
3 EX-99.2 exhibit2.htm EX-99.2 8781
  Complete submission text file 0001299933-06-003242.txt   66478
Mailing Address 11388 SORRENTO VALLEY ROAD SUITE 200 SAN DIEGO CA 92121
Business Address 11388 SORRENTO VALLEY ROAD STE 200 SAN DIEGO CA 92121 8586225200
AVANIR PHARMACEUTICALS (Filer) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: CA | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-15803 | Film No.: 06817036
SIC: 2834 Pharmaceutical Preparations